Seeing further.


We’re advancing our RNA-based treatments so patients with cancers and rare diseases can enjoy the moments that matter.

Learn More

Transforming Immunity. Restoring Hope.

We’re committed to redefining the treatment of certain cancers and rare diseases.

Learn More

Scientists. Believers. People.

At Idera, we’re working hard to translate our nucleic acid science into life-changing medicines.

Discover Idera

The Latest

Keep up with what’s happening at Idera Pharmaceuticals.


Idera Pharmaceuticals Provides 2018 Update and Outlook

Company to Present at the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10,… Read more 

U.S. FDA Grants Fast Track Designation for Idera Pharmaceuticals’ IMO-2125 in Combination with Ipilimumab for Treatment of PD-1 Refractory Metastatic Melanoma

Phase 3 Trial Initiation Planned for First Quarter 2018 CAMBRIDGE, Mass. and EXTON, Pa. , Nov. 29,… Read more 

Idera to Present at the 29th Annual Piper Jaffray Healthcare Conference

CAMBRIDGE, Mass. and EXTON, Pa. , Nov. 27, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc.… Read more 

Learn More


Idera Pharmaceuticals, Inc. Events

Idera Pharmaceuticals, Inc. Events… Read more 

Learn More